{"id":"W2540798315","doi":"10.1016/j.jval.2016.09.1882","title":"Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Boehringer Ingelheim (Canada)","funders":"","keywords":"Empagliflozin; Medicine; Cost–benefit analysis; Quality-adjusted life year; Hazard ratio; Demography; Emergency medicine; Cost effectiveness; Confidence interval; Internal medicine; Type 2 diabetes; Diabetes mellitus; Risk analysis (engineering); Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004106112,0.00008420462,0.0002968436,0.0001431919,0.000008680193,0.000001370544,0.00002718422,0.00001793831,0.000005791989],"category_scores_gemma":[0.0000444258,0.00005276006,0.000006769103,0.0001793905,0.00001939746,0.00003449246,0.0000188494,0.0000555155,8.002438e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001007713,"about_ca_system_score_gemma":0.0004194033,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9147301,"about_ca_topic_score_gemma":0.6222208,"domain_scores_codex":[0.9990517,0.0001942797,0.00021591,0.0001645016,0.000155391,0.0002182435],"domain_scores_gemma":[0.9994821,0.0002188441,0.00007783962,0.0001301092,0.00001730193,0.00007378334],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003584441,0.0001918966,0.977461,0.0003742171,0.00001574781,0.000009890953,0.00007454406,0.0001027455,0.000001929429,0.00007712136,0.00002500296,0.0213074],"study_design_scores_gemma":[0.008938421,0.0006215936,0.9885764,0.001529735,0.000009073133,8.705607e-8,0.00003174971,0.00004969499,0.00005855656,0.00006829354,0.00006531999,0.00005114089],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983863,0.0001267143,0.000006302452,0.0002290242,0.00005769119,0.001107087,0.00002259515,0.000003668557,0.00006057849],"genre_scores_gemma":[0.9996237,0.0001316804,0.00009783119,0.0000674164,0.000004594695,0.00004083419,0.000008610447,0.000008724626,0.00001665523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2925093,"threshold_uncertainty_score":0.3846727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01397248930504762,"score_gpt":0.2453143714053366,"score_spread":0.231341882100289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}